scholarly article | Q13442814 |
P2093 | author name string | Mehdi Yaseri | |
Hamid Reza Khorram Khorshid | |||
Seyed Javad Mowla | |||
Masoud Solaymani-Dodaran | |||
Hassan Ali Mohebbi | |||
Azam Mohammadian | |||
Abouzar Bagheri | |||
Mahmood Tavallaie | |||
Masih Sherafatian | |||
P2860 | cites work | Serum microRNAs are promising novel biomarkers | Q21144238 |
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer | Q21245710 | ||
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells | Q21245767 | ||
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia | Q24633341 | ||
Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 | ||
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
Lung cancer epigenetics: emerging biomarkers | Q28285049 | ||
A human snoRNA with microRNA-like functions | Q28301613 | ||
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma | Q28749302 | ||
Pembrolizumab for the treatment of non-small-cell lung cancer | Q29620851 | ||
Noninvasive staging of non-small cell lung cancer: a review of the current evidence. | Q30761693 | ||
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology | Q30980947 | ||
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells | Q33289523 | ||
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue | Q33331288 | ||
The National Lung Screening Trial: overview and study design | Q33736528 | ||
Evaluation of FTIR spectroscopy as a diagnostic tool for lung cancer using sputum | Q33752158 | ||
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer | Q33756981 | ||
MiR-223 suppresses cell proliferation by targeting IGF-1R. | Q34071730 | ||
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34121219 | ||
miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β. | Q34139102 | ||
MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. | Q34159602 | ||
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. | Q34188647 | ||
Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma | Q34251059 | ||
Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs | Q34513878 | ||
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis | Q34745747 | ||
Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer | Q34775805 | ||
miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma | Q34832407 | ||
Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection | Q34999442 | ||
Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma | Q35653780 | ||
MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. | Q35891213 | ||
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review | Q36037933 | ||
An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. | Q36075260 | ||
MicroRNAs in mammalian development | Q36539270 | ||
MiR-223 deficiency increases eosinophil progenitor proliferation | Q36586129 | ||
miRNAs and apoptosis: RNAs to die for. | Q36617814 | ||
Sputum-based molecular biomarkers for the early detection of lung cancer: limitations and promise | Q37137372 | ||
miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2 | Q37211611 | ||
Control of cell proliferation pathways by microRNAs | Q37289731 | ||
Small nucleolar RNAs in cancer | Q37346566 | ||
Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer | Q37373143 | ||
MiRNAs and cancer | Q37407582 | ||
MicroRNAs-role in lung cancer | Q37679619 | ||
The non-coding transcriptome as a dynamic regulator of cancer metastasis | Q37705696 | ||
Respiratory cytology in the era of molecular diagnostics: a review | Q38012422 | ||
Sputum analysis: non-invasive early lung cancer detection | Q38053994 | ||
miR-223: infection, inflammation and cancer | Q38114927 | ||
miRNAs as non-invasive biomarkers for lung cancer diagnosis | Q38221221 | ||
miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer | Q38347873 | ||
Association of chromosome 19 to lung cancer genotypes and phenotypes | Q38485902 | ||
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. | Q38927623 | ||
Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells | Q38936799 | ||
Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma | Q39233292 | ||
Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. | Q39304020 | ||
MicroRNA-223 regulates FOXO1 expression and cell proliferation | Q39351860 | ||
MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. | Q39407479 | ||
MicroRNA: Biogenesis, Function and Role in Cancer | Q42004179 | ||
Small non-coding RNA biomarkers in sputum for lung cancer diagnosis | Q42789384 | ||
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. | Q43857650 | ||
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. | Q45801517 | ||
miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. | Q48061857 | ||
Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer. | Q53600528 | ||
miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells | Q83147768 | ||
Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer | Q87416668 | ||
P433 | issue | 4 | |
P921 | main subject | sputum | Q259346 |
P304 | page(s) | 189-195 | |
P577 | publication date | 2017-10-01 | |
P1433 | published in | Avicenna Journal of Medical Biotechnology | Q26842226 |
P1476 | title | Altered miR-223 Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer | |
P478 | volume | 9 |
Q90737165 | Circulatory microRNAs: promising non-invasive prognostic and diagnostic biomarkers for parasitic infections |
Q92481902 | Clinical applications of liquid biopsies for early lung cancer detection |
Q93022677 | MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC) |
Q64257284 | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
Q91712683 | Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer |
Q64250163 | miR-223 Regulates Cell Proliferation and Invasion via Targeting PDS5B in Pancreatic Cancer Cells |
Search more.